Dr. Peter Altman and Mr. David McClung, CEO and CFO of BioCardia, respectively, will also be participating in one-on-one meetings with investors at both conferences. If you are an institutional or ...
Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today ...
Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results